Lutetium177J591QualityChecker
Lutetium-177 J591
Utility description: Lutetium-177 J591
Lutetium-177 J591 Quality Checker — Lutetium-177 J591 (Anti-PSMA mAb) for prostate cancer therapy ℹ️ Utility checks critical parameters of Lutetium-177 J591: • Radionuclidic purity (≥99.9%) • Lutetium-177m impurity (≤0.01%) • Radiochemical purity (≥95%) — binding to J591 monoclonal antibody • Free lutetium (≤5%) • Antibody aggregates (≤5%) • pH (6.5–7.5), endotoxins, sterility ⚠️ CRITICAL: Aggregates >5% → risk of immunogenicity and rapid clearance from blood! Free lutetium >5% → accumulation in bone marrow (myelotoxicity)! Usage: Lutetium177J591QualityChecker.exe → demo mode (console output) Lutetium177J591QualityChecker.exe input.csv output.json → evaluate your data Input format: BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,AggregateContentPercent,ProteinConcentrationMgPerMl,pH,EndotoxinsEU,SterilityTest,ProductType Example (sterility: 0=sterile, 1=contaminated): Lu177-J591-2026-001,3700.0,99.98,0.005,98.5,1.0,1.5,2.0,7.0,30.0,0,Therapeutic Supported product types: • Therapeutic — targeted therapy for metastatic castration-resistant prostate cancer (mCRPC) — WHY IS THIS NEEDED? Lutetium-177 J591 is a radioimmunoconjugate based on a humanized monoclonal antibody: • Target: PSMA (Prostate-Specific Membrane Antigen) • Lu-177 half-life: 6.65 days — optimal for antibody delivery • Beta radiation destroys prostate tumor cells and bone metastases • J591 has high affinity for the extracellular domain of PSMA ⚠️ CRITICAL: • Radiochemical purity ≥95% — Lutetium must be firmly chelated (usually DOTA or DTPA conjugated to the antibody). Free lutetium accumulates in bones. • Aggregates ≤5% — Aggregated antibodies are rapidly cleared by the reticuloendothelial system (liver/spleen) and can cause anaphylactic reactions. Control by SEC-HPLC is mandatory. • Lutetium-177m impurity ≤0.01% — Long-lived isomer (T½=160.4 days) creates unnecessary radiation burden. • pH 6.5–7.5 — Antibodies are sensitive to acidity; deviations lead to denaturation and loss of binding. Key features: • Control of aggregates (specific to biologics/antibodies) • Check for long-lived Lu-177m impurity • Assessment of free lutetium level (risk of myelotoxicity) • Narrow pH range for protein stability Critical parameters: • Radionuclidic purity: ≥99.9% • Lutetium-177m impurity: ≤0.01% • Radiochemical purity: ≥95.0% • Free lutetium: ≤5.0% • Aggregates: ≤5.0% • pH: 6.5–7.5 • Endotoxins: ≤175 EU/vial • Sterility: no microbial growth 💡 Usage tips: Radiochemical purity and aggregates are determined by ITLC and SEC-HPLC respectively Lu-177m is controlled by gamma spectrometry The drug requires slow intravenous administration to minimize infusion reactions Specific activity (MBq/mg) is calculated based on total activity and protein concentration ⚠️ Note: Unlike small molecules (peptides), antibodies have a long circulation time in blood (days). This requires high radiochemical purity, as any free isotope will circulate for a long time and irradiate healthy tissues (especially bone marrow). Antibody aggregation is a critical quality parameter absent in small molecules.
input.csv
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,AggregateContentPercent,ProteinConcentrationMgPerMl,pH,EndotoxinsEU,SterilityTest,ProductType Lu177-J591-2026-001,3700.0,99.98,0.005,98.5,1.0,1.5,2.0,7.0,30.0,0,Therapeutic Lu177-J591-2026-002,3500.0,99.85,0.02,94.0,6.5,6.0,2.1,6.8,180.0,0,Therapeutic Lu177-J591-2026-003,3800.0,99.99,0.002,99.0,0.5,0.8,1.9,7.2,20.0,0,Therapeutic
URS & FS — User Requirements and Functional Specification
This document describes the controlled interface and behaviour of Lutetium177J591QualityChecker for Lutetium-177 J591.
Domain limits and critical parameters
- ℹ️ Utility checks critical parameters of Lutetium-177 J591:
- • Radionuclidic purity (≥99.9%)
- • Lutetium-177m impurity (≤0.01%)
- • Radiochemical purity (≥95%) — binding to J591 monoclonal antibody
- • Free lutetium (≤5%)
- • Antibody aggregates (≤5%)
- • pH (6.5–7.5), endotoxins, sterility
- ⚠️ CRITICAL: Aggregates >5% → risk of immunogenicity and rapid clearance from blood!
- Free lutetium >5% → accumulation in bone marrow (myelotoxicity)!
- BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,AggregateContentPercent,ProteinConcentrationMgPerMl,pH,EndotoxinsEU,SterilityTest,ProductType
- Example (sterility: 0=sterile, 1=contaminated):
- ⚠️ CRITICAL:
- • Radiochemical purity ≥95% — Lutetium must be firmly chelated (usually DOTA or DTPA conjugated to the antibody). Free lutetium accumulates in bones.
- • Aggregates ≤5% — Aggregated antibodies are rapidly cleared by the reticuloendothelial system (liver/spleen) and can cause anaphylactic reactions. Control by SEC-HPLC is mandatory.
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file with the exact headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic QC evaluation for Lutetium-177 J591 using input values, approved limits and domain rules. | High | Each input row receives a PASS / WARNING / FAIL status. |
| URS-003 | The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility. | High | Schema and conversion errors are explicitly reported. |
| URS-004 | The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present. | High | A critical deviation causes FAIL or a separate critical finding. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings and failures. | High | JSON is suitable for LIMS/ELN/MES integration and QA/QC review. |
| URS-006 | The utility shall not use machine learning to decide conformance. | Medium | The result is based on explicit rules, thresholds and input values. |
| URS-007 | The utility shall preserve traceability between batch number, input values, applied rules and final status. | High | The output contains the batch identifier and the list of checked parameters. |
| URS-008 | The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators. | Medium | URS & FS, input.csv/output.json contract and test scenarios are supplied with the utility. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string | Lu177-J591-2026-001 | Batch or lot identifier used for traceability. |
| 2 | TotalActivityMBq | decimal | 3700.0 | Radioactivity value used for release, decay or dose-related assessment. |
| 3 | RadionuclidicPurityPercent | string | 99.98 | Radionuclidic purity; a critical radiation-safety and impurity parameter. |
| 4 | Lutetium177mImpurityPercent | string | 0.005 | Controlled impurity or residual material. |
| 5 | RadiochemicalPurityPercent | string | 98.5 | Radiochemical purity; confirms the labelled chemical form and binding quality. |
| 6 | FreeLutetiumPercent | decimal | 1.0 | Free radionuclide / unbound species; important for non-target uptake and toxicity. |
| 7 | AggregateContentPercent | decimal | 1.5 | Controlled input parameter used by the deterministic QC rules. |
| 8 | ProteinConcentrationMgPerMl | decimal | 2.0 | Controlled input parameter used by the deterministic QC rules. |
| 9 | pH | decimal | 7.0 | Solution pH; relevant for stability, compatibility and administration. |
| 10 | EndotoxinsEU | decimal | 30.0 | Bacterial endotoxins; critical for parenteral administration. |
| 11 | SterilityTest | flag / boolean | 0 | Sterility result; critical release parameter. |
| 12 | ProductType | string | Therapeutic | Controlled input parameter used by the deterministic QC rules. |
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,AggregateContentPercent,ProteinConcentrationMgPerMl,pH,EndotoxinsEU,SterilityTest,ProductType Lu177-J591-2026-001,3700.0,99.98,0.005,98.5,1.0,1.5,2.0,7.0,30.0,0,Therapeutic Lu177-J591-2026-002,3500.0,99.85,0.02,94.0,6.5,6.0,2.1,6.8,180.0,0,Therapeutic Lu177-J591-2026-003,3800.0,99.99,0.002,99.0,0.5,0.8,1.9,7.2,20.0,0,Therapeutic
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate the header and expected columns. |
| FS-002 | Schema validation | Check mandatory fields and column count; report unknown or missing key fields. |
| FS-003 | Type conversion | Convert numeric, flag and text values; invalid formats are recorded as row-level errors. |
| FS-004 | Domain rule engine | Apply domain rules for Lutetium-177 J591, including critical limits from the utility description and approved specification. |
| FS-005 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-006 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-007 | Audit support | Keep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation. |
| FS-008 | Integration contract | Support the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation. |
Example output.json
{
"utilityId": "lutetium177-j591-quality-checker",
"api": "Lutetium-177 J591",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"checks": [
{
"parameter": "BatchNumber",
"value": "Lu177-J591-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "TotalActivityMBq",
"value": "3700.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadionuclidicPurityPercent",
"value": "99.98",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Lutetium177mImpurityPercent",
"value": "0.005",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadiochemicalPurityPercent",
"value": "98.5",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "FreeLutetiumPercent",
"value": "1.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "AggregateContentPercent",
"value": "1.5",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "ProteinConcentrationMgPerMl",
"value": "2.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": []
}
OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| OQ-001 | Valid sample row | PASS or acceptable WARNING according to the rules. |
| OQ-002 | Mandatory column missing | Schema error or FAIL. |
| OQ-003 | Non-numeric value in numeric field | Type-conversion error. |
| OQ-004 | Critical parameter outside limit | FAIL and critical finding. |
| PQ-001 | User real batch/lot | Reviewed result with input.csv and output.json retained. |
QA/QC and change control
- Do not rename columns without updating the validator and test set.
- Retain
input.csv,output.json, executable version and checksum. - Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.
Included in packages
Andrology QC Suite
QC package for andrology: androgens, erectile-dysfunction medicines, BPH/prostate products, fertility and related hormonal checks.
OpenBiopharmaceuticals Core QC Suite
Focused QC utility package for biologic products: HCP, mAbs, biosimilars, proteins/peptides, sterility, endotoxins and key release checks.
OpenBiopharmaceuticals Extended QC Suite
Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.
OpenImmunology QC Suite
QC utility package for immunology: monoclonal antibodies, biosimilars, immunomodulators, immunosuppressants, ELISA/SPR, HCP, protein characterization, sterility and pyrogen/release checks.
OpenPetRad3: expanded PET/SPECT and radiopharmaceutical QC package
A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.
OpenRadiology QC Suite
QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.
OpenRPH isotope family: beta-emitting therapy
Lu-177, Y-90, Ho-166, Re-188, Sm-153, Sr-89, P-32, Cu-67 and Tb-161.
OpenRPH organ/system: bone and musculoskeletal
Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.
OpenRPH organ/system: hepatobiliary and GI
HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.
OpenRPH organ/system: oncology and theranostics
Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.
OpenRPH organ/system: renal and urinary
Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.
OpenRPH use case: radionuclide therapy and theranostics
Lu-177, Ac-225, Ra-223, Y-90, Ho-166, Sm-153, Sr-89, Re-188, Tb-161, I-131 and other therapeutic radiopharmaceuticals: activity, purity, free metal, daughters and toxicological constraints.
OpenRPH workflow: generators and isotope purity
Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.
OpenRPH workflow: imaging QC and quantitative interpretation
Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH workflow: stability, storage, decay and waste
Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.
OpenRPH workflow: synthesis, labelling and kit reconstitution
Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.
OpenRPH: combined radiopharmaceutical QC package
RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.
OpenUrology QC Suite
QC package for urology: BPH, urolithiasis, overactive bladder, urinary-tract infection medicines and supporting antimicrobial QC checks.
Open